Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Slides:

Advertisements

Similar presentations

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Advertisements

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST) Kirsten E. Fleischmann,

Downstream coronary effects of drug-eluting stents

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial Erik Kjøller, MD, DMSc, Jørgen Hilden,

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy.

Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes Hélène Eltchaninoff, MD, Eric Durand,

Force- and relaxation-frequency relations in patients with diastolic heart failure Takashi Yamanaka, MD, Katsuya Onishi, MD, FACC, Masaki Tanabe, MD,

Volume 146, Issue 5, Pages (November 2014)

The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction Mehmet Ergelen, MD, Sevket.

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi- intervention in type 2 diabetes: The randomized controlled Asker.

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population Richard K. Cheng, MD, MS,

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study.

Society of Thoracic Surgeons 2008 cardiac risk models predict in-hospital mortality of heart valve surgery in a Chinese population: A multicenter study

Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.

Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan.

Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Anh L. Bui, MD, Maria.

Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice Manesh R.

Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular.

Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT)

Manuel J. Antunes, MD, PhD, DSc

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance Judith.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

A contemporary analysis of pulmonary hypertension in patients undergoing mitral valve surgery: Is this a risk factor? Daniel H. Enter, MD, Anthony Zaki,

Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Digoxin Use and Lower 30-day All-cause Readmission for Medicare Beneficiaries Hospitalized for Heart Failure Ali Ahmed, MD, MPH, Robert C. Bourge, MD,

Nancy M. Albert, PhD, Gregg C. Fonarow, MD, William T

Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure Jacques D. Donzé, MD, MSc, Patrick.

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Increased late mortality after coronary artery bypass surgery complicated by isolated new-onset atrial fibrillation: A comprehensive propensity-matched.

Prognostic Importance of Low Admission Serum Creatinine Concentration for Mortality in Hospitalized Patients Charat Thongprayoon, MD, Wisit Cheungpasitporn,

Should asymptomatic patients discharged with lower hemoglobin expect worse outcomes after valve surgery? Niv Ad, MD, Sari D. Holmes, PhD, Deborah J.

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis Christophe de Meester, MS, Agnès Pasquet,

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Repeated Heart Rate Measurement and Cardiovascular Outcomes in Left Ventricular Systolic Dysfunction Victoria Hamill, PhD, Ian Ford, PhD, Kim Fox, MD,

The effect of regionalization on outcome in pulmonary lobectomy: A Canadian national study Christian J. Finley, MD, MPH, Anna Bendzsak, MD, George Tomlinson,

Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study Vasilios Papademetriou, MD, DSc, Eric.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

Aamir Jeewa, MD, Cedric Manlhiot, BS, Paul F

One-year results of thoracic endovascular aortic repair for blunt thoracic aortic injury (RESCUE trial) Ali Khoynezhad, MD, PhD, FACS, Carlos E. Donayre,

Competing risks need to be considered in survival analysis models for cardiovascular outcomes Marianne Huebner, PhD, Martin Wolkewitz, Dr Sc Hum, Maurice.

Effect of aortic aneurysm replacement on outcomes after bicuspid aortic valve surgery: Validation of contemporary guidelines Daniel Rinewalt, MD, Patrick.

Impact of the second internal thoracic artery on short- and long-term outcomes in obese patients: A propensity score matched analysis Umberto Benedetto,

Risks and Outcomes of Acute Kidney Injury Requiring Dialysis After Cardiac Transplantation Janet M. Boyle, MD, Soundous Moualla, MD, Susana Arrigain,

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Arterial lactate before initiation of venoarterial extracorporeal membrane oxygenation for postcardiotomy shock improves postimplant outcome prediction

Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction Marjan Mujib, MD, MPH, Kanan Patel, MBBS, MPH,

Nilay S. Shah, MD, MPH, David Leonard, PhD, Carrie E

Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W

Ali Ahmed, MD, Gregg C. Fonarow, MD, Yan Zhang, MS, MSPH, Paul W

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure Cherinne Arundel,

Michael A. Coady, MD, John A. Rizzo, PhD, Graeme L

Francisco Alcocer, MD, Marjan Mujib, MD, Bruce Lowman, MD, Mark A

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Presentation transcript:

Outcomes in ambulatory chronic systolic and diastolic heart failure: A propensity score analysis Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E. Love, PhD, David C. Goff, MD, PhD, Dalane W. Kitzman, MD American Heart Journal Volume 152, Issue 5, Pages 956-966 (November 2006) DOI: 10.1016/j.ahj.2006.06.020 Copyright © 2006 Mosby, Inc. Terms and Conditions

Figure 1 Absolute standardized differences in covariates between patients with SHF and DHF before and after PS matching. American Heart Journal 2006 152, 956-966DOI: (10.1016/j.ahj.2006.06.020) Copyright © 2006 Mosby, Inc. Terms and Conditions

Figure 2 Kaplan-Meier plots demonstrating cumulative risk of mortality due to all causes (A), cardiovascular causes (B), and heart failure (C) in propensity score matched patients with SHF and DHF. American Heart Journal 2006 152, 956-966DOI: (10.1016/j.ahj.2006.06.020) Copyright © 2006 Mosby, Inc. Terms and Conditions

Figure 3 Kaplan-Meier plots demonstrating cumulative risk of first hospitalizations due to all causes (A), cardiovascular causes (B), and worsening heart failure (C) in propensity score matched patients with SHF and DHF. American Heart Journal 2006 152, 956-966DOI: (10.1016/j.ahj.2006.06.020) Copyright © 2006 Mosby, Inc. Terms and Conditions

Figure 4 HR and 95% CI for all-cause mortality in subgroups of patients with DHF compared with SHF. American Heart Journal 2006 152, 956-966DOI: (10.1016/j.ahj.2006.06.020) Copyright © 2006 Mosby, Inc. Terms and Conditions